STE 7715
No. of Pages 5, Model 5G
23 January 2015
2
W. Zhang et al. / Steroids xxx (2015) xxx–xxx
86
87
88
89
90
91
123
124
dependent upon steric factors than chromic acid oxidation [23].
Hence, there is clearly a need for a more efficient method of the
oxidation of sterol with DDQ. Herein we report the oxidation of
3b-hydroxysteroids to 3-keto steroids with DDQ/TEMPO coupled
at room temperature, where catalytic amounts of TEMPO are used
in combination with DDQ as stoichiometric oxidation.
17.2, 16.5, 14.7, 11.7 ppm. HRMS: [M+] calcd for C27H42O3:
414.3134; found: 414.3138.
125
2.3. Methyl 3-oxo-androst-4-ene-17b-carboxylate (2b)
126
127
128
129
130
131
132
Methyl 3-oxo-androst-4-ene-17b-carboxylate (2b) from 3b-
hydroxy-5-androstene-17b-carboxylate (1b). 1H NMR (600 MHz,
CDCl3): d: 5.73 (s, 1H), 3.66 (s, 3H), 1.18 (s, 3H), 0.69 (s, 3H). 13C
NMR (150 MHz, CDCl3): d: 199.6, 174.5, 124.1, 118.1, 56.2, 55.2,
54.9, 53.5, 44.0, 42.7, 38.1, 37.8, 35.7, 34.0, 32.3, 31.7, 24.4, 23.6,
20.9, 19.1, 13.5 ppm. HRMS: [M+] calcd for C21H30O3: 330.2195;
found: 330.2199.
92
2. Experiment
93
94
Melting points were determined using a WRS-1B apparatus and
were uncorrected. The 1H and 13C NMR spectra were recorded on
600/150 MHz NMR spectrometers (a Bruker AV600 spectrometer),
using tetramethylsilane (TMS) as the internal standard and CDCl3
as the solvent. High resolution mass (HRMS) spectra were obtained
in ESI mode on a Finnigan MAT95XP HRMS system (Thermo Elec-
tron Corporation). Diffraction experiments for oxidation product
were carried out on with Mo Ka radiation (k = 0.71073 Å) using a
bruker SMART APEX CCD diffractometer at 296 K. All chemicals
were of reagent grade and used as commercially purchased with-
out further purification. All solvents were dried and distilled before
95
96
97
133
2.4. Methyl 3-oxo-androst-4,6-diene-17b-carboxylate (3b)
98
99
134
135
136
137
138
139
140
Methyl 3-oxo-androst-4,6-diene-17b-carboxylate (3b) from 3b-
hydroxy-5-androstene-17b-carboxylate (1b). 1H NMR (600 MHz,
CDCl3): d: 6.10 (s, 2H), 5.70 (s, 1H), 3.67 (s, 3H), 1.10 (s, 3H), 0.74
(s, 3H). 13C NMR (150 MHz, CDCl3): d: 197.6, 175.5, 155.9, 132.6,
126.1, 121.1, 55.7, 48.0, 46.5, 42.5, 39.0, 38.9, 38.1, 31.0, 28.5,
20.9, 20.3, 20.1, 19.1, 18.9, 13.7 ppm. HRMS: [M+] calcd for
C21H28O3: 328.2038; found: 328.2042.
100
101
102
103
104
105
use. The reactions were monitored by TLC on silica gel 60 F254
.
Chromatography was conducted by using 200–300 mesh silica gel.
106
2.1. General procedure
141
2.5. 25(R)-4,6-Spirostadien-3-one (2c)
107
108
109
110
111
112
113
114
115
To a stirred solution of steroids (1 mmol) in dry CH2Cl2 at 0 °C
was added DDQ (1.2 mmol or 2.2 mmol) and TEMPO (0.1 mmol).
After the addition, the mixture was warmed to room temperature
and stirred for the required time until completion by TLC. The mix-
ture was filtered on Celite, the filtrate was respectively washed
with 2% sodium hydroxide, saturated sodium chloride solution
and distilled water. The solution was dried, concentrated in a rot-
ovap. The residue was then purified by flash chromatography
(petroleum ether/ethyl acetate) to obtain the desired product.
142
143
144
145
146
147
148
149
25(R)-4,6-Spirostadien-3-one (2c) from (3b, 25R)-spirost-5-en-
3-ol (1c). 1H NMR (600 MHz, CDCl3): d: 6.11 (d, J = 2.4 Hz, 2H),
5.67 (s, 1H), 1.26 (s, 3H), 0.98 (d, J = 6.4 Hz, 3H), 0.88 (s, 3H), 0.79
(d, J = 6.4 Hz, 3H). 13C NMR (150 MHz, CDCl3): d: 199.7, 163.8,
141.0, 128.1, 123.9, 109.5, 80.6, 67.1, 62.2, 53.3, 50.9, 41.8, 41.6,
39.7, 37.4, 36.3, 34.1, 34.0, 31.5, 31.4, 30.4, 28.9, 20.6, 17.3, 16.5,
16.4, 14.6 ppm. HRMS: [M+H+] calcd for C27H39O3: 411.2821;
found: 411.2825.
150
2.6. Pregna-4,6-diene-3,20-dione (2d)
116
2.2. 5
a-Spirostan-3-one (2a)
151
152
153
154
155
156
157
Pregna-4,6-diene-3,20-dione (2d) from 3b-hydroxy-5-preg-
nene-20-one (1d). 1H NMR (600 MHz, CDCl3): d: 6.12 (d,
J = 2.4 Hz, 2H), 5.69 (s, 1H), 2.15 (s, 3H), 1.12 (s, 3H), 0.72 (s, 3H).
13C NMR (150 MHz, CDCl3): d: 208.8, 199.5, 163.3, 140.6, 128.3,
123.9, 63.4, 53.8, 50.7, 44.8, 38.7, 37.7, 36.2, 34.0, 34.0, 31.6,
24.0, 23.0, 20.8, 16.4, 13.4 ppm. HRMS: [M+] calcd for C21H28O2:
312.2089; found: 312.2091.
-Spirostan-3-one (2a) from tigogenin (1a). 1H NMR
117
118
119
120
121
122
5
a
(600 MHz, CDCl3): d: 4.40 (q, J = 11.2 Hz, 1H), 3.39 (m, 1H), 3.37
(t, J = 10.8 Hz, 1H), 1.02 (s, 3H), 0.96 (d, J = 3.6 Hz, 3H), 0.79 (s,
3H), 0.78 (d, J = 2.0 Hz, 3H) ppm. 13C NMR (150 MHz, CDCl3): d:
212.0, 109.3, 80.8, 67.0, 62.3, 56.3, 54.0, 46.7, 44.8, 41.7, 40.7,
40.0, 38.6, 38.3, 35.8, 35.2, 32.0, 31.8, 31.4, 30.4, 29.0, 28.9, 21.3,
Table 1
The oxidation of tigogenin with DDQ in the presence of TEMPO.
O
O
O
DDQ/TEMPO
solvent
O
O
HO
2a
1a
Entry
Solvent
Reaction time (h)
Yield (%)
1
2
3
4
5
6
CH2Cl2
Toluene
Dioxane
CHCl3
Ethyl acetate
ClCH2CH2Cl
24
24
24
24
24
24
80.2
30.4
50.8
73.6
36.4
71.4
Q1
Please cite this article in press as: Zhang W et al. Effective and mild method for converting 3b-hydroxysteroids to 3-keto steroids via DDQ/TEMPO. Steroids